Darlene Dobkowski, Managing Editor for CURE® magazine, has been with the team since October 2020 and has covered health care in other specialties before joining MJH Life Sciences. She graduated from Emerson College with a Master’s degree in print and multimedia journalism. In her free time, she enjoys buying stuff she doesn’t need from flea markets, taking her dog everywhere and scoffing at decaf.
Chemo-Related Hearing Loss May Have Emotional, Social Impacts in Testicular Cancer Survivors
January 12th 2023Testicular cancer survivors who were treated with cisplatin-based chemotherapy may have hearing loss or ringing of the ears, which may significantly affect certain parts of life including sleep and concentration, among other factors.
FDA Approves First Gene Therapy for Non-Muscle Invasive Bladder Cancer
December 16th 2022Adstiladrin represents the first gene therapy approved by the FDA for the treatment of patients with high-risk non-muscle invasive bladder cancer who are resistant to BCG, the first-line standard of care for these patients.
‘Cheers’ Actress Kirstie Alley Dies Shortly After Receiving Colon Cancer Diagnosis
December 6th 2022Actress Kirstie Alley, who is known for roles in “Cheers,” “Look Who’s Talking’” and other television shows and movies, died a short time after receiving a colon cancer diagnosis, according to a family statement.
FDA Approval of Elahere Represents a ‘Step Forward’ for Platinum-Resistant Ovarian Cancer Subset
November 22nd 2022One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.